Johnson & Johnson is set to present 11 oral presentations at WCLC and ESMO 2024, showcasing advancements in solid tumor treatments for lung, bladder, prostate, and colorectal cancers.
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.